Zimbabwe recalls Azithromycin batch due to quality defects.

Spyre Therapeutics shares surge on positive Phase 2 ulcerative colitis trial results.

Reach Surgical's iREACH IRIS stapler received CE Mark approval for real-time force feedback.

OBI Pharma presents GlycOBI platform for next-gen antibody-drug conjugates at 2026 AACR meeting.

Study finds half of GLP-1 users report side effects like nausea, fatigue, and bleeding.

FDA grants Fast Track status to Arbutus' hepatitis B drug imdusiran.

Indian pharma growth faces pressure from US market challenges.

Wuxi Tairex launches AI hospital platform with virtual consultation rooms for clinical training.

BioNTech and DualityBio report effective antibody-drug conjugate for HER2-positive recurrent endometrial cancer.

Central Ayurveda Research Institute receives ISO accreditation for lab testing.